Resona Asset Management Co. Ltd. lowered its position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 4.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 36,973 shares of the company’s stock after selling 1,755 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in Astera Labs were worth $4,002,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the company. Lido Advisors LLC increased its position in Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after purchasing an additional 57 shares during the period. Perigon Wealth Management LLC lifted its position in Astera Labs by 6.2% during the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after purchasing an additional 73 shares during the period. Sound Income Strategies LLC boosted its stake in shares of Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after purchasing an additional 76 shares during the last quarter. Venturi Wealth Management LLC boosted its stake in shares of Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after purchasing an additional 84 shares during the last quarter. Finally, Goldstein Advisors LLC grew its position in shares of Astera Labs by 5.8% during the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock worth $268,000 after buying an additional 88 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently weighed in on ALAB shares. Barclays increased their price objective on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Royal Bank Of Canada lifted their target price on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, May 6th. Jefferies Financial Group reiterated a “buy” rating and set a $270.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Needham & Company LLC increased their price target on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Finally, Rothschild & Co Redburn initiated coverage on Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target on the stock. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average target price of $265.75.
Insider Activity
In other Astera Labs news, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the completion of the transaction, the director owned 286,863 shares of the company’s stock, valued at $131,492,261.94. This trade represents a 2.87% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 2,040,691 shares of company stock worth $507,675,380. Corporate insiders own 10.40% of the company’s stock.
Astera Labs Stock Performance
NASDAQ:ALAB opened at $412.97 on Monday. Astera Labs, Inc. has a 1 year low of $88.18 and a 1 year high of $499.48. The stock has a 50-day moving average price of $335.76 and a two-hundred day moving average price of $214.94. The stock has a market cap of $70.79 billion, a price-to-earnings ratio of 279.03, a PEG ratio of 4.65 and a beta of 3.66.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter last year, the firm posted $0.33 earnings per share. Astera Labs’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts forecast that Astera Labs, Inc. will post 1.88 earnings per share for the current year.
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
